LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: How many times can parvovirus B19-related anemia recur in solid organ transplant recipients?

Gosset, C / Viglietti, D / Hue, K / Antoine, C / Glotz, D / Pillebout, E

Transplant infectious disease : an official journal of the Transplantation Society

2012  Volume 14, Issue 5, Page(s) E64–70

Abstract: Parvovirus B19 (PB19) infection is known to cause acute erythroblastopenia-mediated anemia in solid ... organ transplant (SOT) recipients. Intravenous immunoglobulins (IVIg) and the decrease of immunosuppression level ... the schedule of IVIg administrations. However, a few reports have shown that PB19-related anemia can recur ...

Abstract Parvovirus B19 (PB19) infection is known to cause acute erythroblastopenia-mediated anemia in solid organ transplant (SOT) recipients. Intravenous immunoglobulins (IVIg) and the decrease of immunosuppression level are supposed to induce a long-term remission, although no consensus exists about the dose and the schedule of IVIg administrations. However, a few reports have shown that PB19-related anemia can recur despite this treatment, with a maximum of 3 recurrences reported. In this report, we describe in detail the cases of 2 kidney recipients with PB19 infection. They experienced, respectively, 9 and 7 PB19-related anemia recurrences. Immunosuppression level was decreased and IVIg were administered at each recurrence followed by a transitory normalization of hemoglobin level and a decrease of serum PB19 viral load. Episodes were separated by several months. These patients raise an original therapeutic management question about a frequent viral infection in SOT recipients. One patient is currently receiving IVIg every 3 months as a secondary prophylaxis without recurrence to date. These 2 case reports are followed by a review of the literature.
MeSH term(s) Adult ; Anemia/etiology ; Anemia/prevention & control ; Humans ; Immunoglobulins, Intravenous/therapeutic use ; Kidney Transplantation/adverse effects ; Male ; Parvoviridae Infections/complications ; Parvoviridae Infections/virology ; Parvovirus B19, Human/isolation & purification ; Recurrence
Chemical Substances Immunoglobulins, Intravenous
Language English
Publishing date 2012-10
Publishing country Denmark
Document type Case Reports ; Journal Article ; Review
ZDB-ID 1476094-0
ISSN 1399-3062 ; 1398-2273
ISSN (online) 1399-3062
ISSN 1398-2273
DOI 10.1111/j.1399-3062.2012.00773.x
Shelf mark
Zs.A 5100: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top